Enter your name and email address to receive an update when we post new content.
Last week, a blistering opinion piece on The New York Times editorial page focused on the coziness of the relationship between the American Cancer Society and Walgreens.
The piece initially triggered criticism by ACS officials, but then—with no fanfare whatsoever—the society’s CEO called on the drug store chain, as well as others, to stop selling tobacco products.
The American Cancer Society prefers to avoid public confrontation with corporate donors, even those who make money by selling tobacco products.
“We have come to the conclusion that in the case of Walgreens, CVS, and other business partners, the best strategy is to work with them rather than against them,” said Robert Youle, vice chair of the board of the American Cancer Society and an attorney with the Denver firm Sherman & Howard.
Almost one decade ago, Laurie Fenton-Ambrose, president and CEO of the Lung Cancer Alliance, described the National Lung Screening Trial as “failed” and “outdated.”
The Department of Defense announced the availability of several grants through its Ovarian Cancer Research Program and its Lung Cancer Research Program.
Following an explosion of criticism, NCI said funding for community oncology clinics would not be interrupted.
In “an open letter to the cancer community” April 10, NCI Director Harold Varmus assured researchers that funding for the NCI Community Clinical Oncology Program sites would continue as it morphs into the NCI Community Oncology Research Program.
For a good time, go to the Medicare database and key in the name of your physician friend, foe, or whatever, and presto!—you will see how much that person had billed Medicare in 2012.
This will make for hours of guilty pleasure, especially if you are willing to set aside concerns about—not just privacy—but accuracy.
President Obama signed a bill authorizing $126 million for pediatric medical research over the next 10 years, following a rare showing of bipartisanship on Capitol Hill.
The American Association for Cancer Research presented its 2014 awards at its annual meeting, held April 5-9 in San Diego. The AACR also inaugurated its officers for the next year during its annual business meeting. Carlos Arteaga was named president of the organization.
Patricia Goldsmith named CEO of CancerCare
Becky DeKay named president of the Association of Community Cancer Centers
MD Anderson Cancer Center partners with GlaxoSmithKline
AACR taking applications for SU2C-Cancer Research UK Fellowship
Group Chairs: Research in "Crisis"
The chairs of the adult clinical trials groups that make up the NCI National Clinical Trials Network said in a letter that recent budget cuts have triggered a “crisis” in clinical research.
Simultaneously, a statement by the president of the American Society of Clinical Oncology, Clifford Hudis, amplified the concerns of the group chairs, and pointed to a separate problem in NCI’s transition to the new structure of clinical research: a three-month gap in funding for community oncology clinics engaged in institute-funded research.
Cancer research remains underfunded, and the U.S. cancer care system as a whole may be unprepared to handle an aging population, according to two separate reports from the American Association for Cancer Research and the American Society of Clinical Oncology.
Current Medicare policies do not adequately reimburse cancer care provided in the community setting, the Community Oncology Alliance and the U.S. Oncology Network said in a joint, open letter to members of Congress.
The American Association for Cancer Research named its 2014 class of elected fellows of the AACR Academy. The fellows will be inducted at the association’s annual meeting in San Diego, April 5-9.
PCORI Forms Clinical Trials Advisory Panel
Samuel Broder named executive VP at Intrexon Corporation
Marion Couch named chair of IU Head and Neck Surgery
John Powderly II honored by ACCC
Two foundations offer $300,000 for neuroendocrine tumor lines
Fred Hutch honors thirteen graduate students
Community Oncology Alliance publishes IV Fluid Shortage Survey
NCCN Updates colorectal assessment guidelines